CrossrefInfokarte
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
Neuropsychiatric Disease and Treatment · 2011-05 · 303
DOI: 10.2147/ndt.s18333 ↗Abstract
Kein Abstract verfügbar.
EUVIMED